SCHEMBL31723173

SCHEMBL31723173

Cc1ccc2oc(-c3cccc(F)c3)c(C(=O)O)c(=O)c2c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.77
KDM4E B2RXH2 7/20 0.77
ALDH1A1 P00352 6/20 0.77
HPGD P15428 4/20 0.77
SMN1; SMN2 Q16637 3/20 0.77
MEN1 O00255 2/20 0.77
KMT2A Q03164 2/20 0.77
NPC1 O15118 2/20 0.77
RAB9A P51151 2/20 0.77
HTT P42858 1/20 0.77
ANO1 Q5XXA6 6/20 0.53
CSNK2A2 P19784 4/20 0.51
CSNK2B P67870 4/20 0.51
CSNK2A1 P68400 4/20 0.51
TP53 P04637 4/20 0.51
CYP3A4 P08684 3/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
HSD17B10 Q99714 2/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20918191 1.00 MAPT (0.77) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL31723167 0.91 MAPT (0.62) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL28427603 0.91 MAPT (0.62) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL20918213 0.90 MAPT (0.85) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL31723182 0.90 MAPT (0.85) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL20918210 0.89 MAPT (0.74) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL31723169 0.89 MAPT (0.74) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL20918175 0.87 ALDH1A1 (0.57) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL31723124 0.87 ALDH1A1 (0.57) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL31723161 0.86 GABRP (0.56) MAPTKDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed